Loading asset research
XBiotech Inc. Common Stock
XBITNasdaq · USD · StocksQuote as of · Exchange session not verified$2.19
+0.92%
Today
XBIT
Loading 1D prices…
Market cap
$66.8M
Volume
31.3K
52w high
$3.4452w low
$2.09Company profile
XBiotech Inc. Common Stock
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
AUSTIN, TX, United States
Employees
87
Fiscal year end
1231
CIK
1626878
Session & valuation
Open$2.19
Previous close$2.17
Day high$2.21
Day low$2.18
30-day avg. volume43.6K
Outstanding shares30.5M
Diluted EPS-$1.49
Latest annual period
P/E (trailing)-1.47
P/E (forward)16.85
Price / book0.52
Beta0.85
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| DWTXDogwood Therapeutics Inc. Common Stock | $65.9M | $0.00 | — | -$7.13 | +3.19% | Buy |
| APLMApollomics Inc. Class A Ordinary Shares | $67.6M | $8.5M | -128.69% | -$52.80 | -2.75% | Unrated |
| RNTXRein Therapeutics Inc. Common Stock | $67.7M | $0.00 | — | -$1.96 | +1.31% | Buy |
| SPROSpero Therapeutics Inc. Common Stock | $65.8M | $12.6M | +68.11% | $0.15 | +0.89% | Buy |
| GOSSGossamer Bio Inc. Common Stock | $65.6M | $48.5M | -351.49% | -$0.75 | -6.12% | Hold |